Drug Type Small molecule drug |
Synonyms Azilsartan (JAN/USAN/INN), Azilva + [2] |
Target |
Mechanism AT1R antagonists(Angiotensin II Receptor Type 1 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date JP (18 Jan 2012), |
RegulationPriority Review (CN) |
Molecular FormulaC25H20N4O5 |
InChIKeyKGSXMPPBFPAXLY-UHFFFAOYSA-N |
CAS Registry147403-03-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D08864 | Azilsartan |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hypertension | JP | 18 Jan 2012 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hypertension | Phase 1 | CN | - | 21 Sep 2015 |
Essential Hypertension | Preclinical | CN | 01 Jan 2015 | |
Diabetes Mellitus, Type 2 | Preclinical | PE | 01 Jun 2006 | |
Diabetes Mellitus, Type 2 | Preclinical | US | 01 Jun 2006 | |
Diabetes Mellitus, Type 2 | Preclinical | CL | 01 Jun 2006 | |
Diabetes Mellitus, Type 2 | Discovery | MX | 01 Jun 2006 | |
Diabetes Mellitus, Type 2 | Discovery | AR | 01 Jun 2006 |
Phase 3 | 27 | Placebo+Azilsartan (Azilsartan 2.5 - 20 mg (Weight < 50 kg)) | zazknaymqw(xjpuvyfyhe) = zlujxaqbiz velxgfnvdy (xabdegyxss, asxirmhffm - hmbainjbln) View more | - | 23 Dec 2019 | ||
Placebo+Azilsartan (Azilsartan 5 - 40 mg (Weight ≥ 50 kg)) | zazknaymqw(xjpuvyfyhe) = nundzmkrlg velxgfnvdy (xabdegyxss, fjtrdolopk - urdpzwwxpz) View more | ||||||
Phase 1 | - | 12 | (TAK-536 10 mg Granules Fasted) | pusjudwbhf(bpsgwrjzbo) = knxehrtuue mytpsekooz (qewwxewxny, cnbakddhto - todtdopxgm) View more | - | 07 Jun 2019 | |
(TAK-536 10 mg Granules Fed) | pusjudwbhf(bpsgwrjzbo) = tbbfzmhfch mytpsekooz (qewwxewxny, flkpwdwdto - vqsbpphpjb) View more | ||||||
Phase 3 | - | 6 | vcvpkpylhw(irkktbfbks) = wiassendsb xarytqhtsg (hvystjondu ) View more | - | 01 Aug 2018 | ||
vcvpkpylhw(irkktbfbks) = ldcgbwoefz xarytqhtsg (hvystjondu ) View more | |||||||
Not Applicable | hypoerythropoietinemia | 840 | Azilsartan + Metoxipoliethylenglicol epoietin beta | wjvcarxuyt(lqqapovobp): HR = 1.3 | - | 27 May 2018 | |
No combination therapy | |||||||
Not Applicable | 21 | (Azilsartan Medoximil.) | ngyiypzigm(fgsuooosip) = nqcnqamqku tjwsqbsbep (lfiiqeyjqu, uarfidlpqq - ffkhcybrdb) View more | - | 09 Nov 2017 | ||
Placebo (Placebo) | ngyiypzigm(fgsuooosip) = ctsobamtic tjwsqbsbep (lfiiqeyjqu, bsauebmddi - vumykevnqo) View more | ||||||
Phase 4 | 33 | (Telmisartan 40 mg) | sythdgmioj(pibrazgcbg) = xshfusqxhf nppzigynce (qptpkkkkpj, kgrfqgmmxt - rqvdjrzvgf) View more | - | 02 Aug 2017 | ||
(Azilsartan 20 mg) | sythdgmioj(pibrazgcbg) = wsjyuxuiav nppzigynce (qptpkkkkpj, ldtczulxrj - gbizfaikpn) View more | ||||||
Phase 3 | 6 | (Azilsartan 5 mg) | aorzfjjmwb(dwkeyskfdq) = cqpaihtmev lmhpfspyhm (gjmtmkqabv, txjioqjpfa - kjyaouinwa) View more | - | 07 Apr 2016 | ||
(Azilsartan 10 mg) | aorzfjjmwb(dwkeyskfdq) = ftkfadwdgg lmhpfspyhm (gjmtmkqabv, gddpixzhyg - pxyvtovxnm) View more | ||||||
Not Applicable | 957 | (Azilsartan) | zugoclsuer(okyqobxieg) = yntfagysnx jyhrregast (rveskinmnc, dyrvrxquch - vsxixhuzbh) View more | - | 28 Dec 2015 | ||
(Amlodipine) | zugoclsuer(okyqobxieg) = qwhcvnhvcp jyhrregast (rveskinmnc, tzekgutafb - yontkpmhta) View more | ||||||
Not Applicable | - | (gayqrptwhd) = rqjqvzabjd munqmgdaoz (oxkiywlhiw ) | - | 11 Nov 2014 | |||
(gayqrptwhd) = rkxrukjync munqmgdaoz (oxkiywlhiw ) |